Press release EUROIMMUN today announced that as part of the transition to the new EU In Vitro Diagnostics Regulation 2017/746 (IVDR), risk class A products have been declared IVDR-compliant. With the IVDR conformity assessment of class A products carried out under its own responsibility, EUROIMMUN has reached an important milestone in the IVDR transition. This […]
Press release CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19 EUROIMMUN today announced the launch of two CE marked assays – the Anti-SARS-CoV-2 RBD ChLIA (IgG) and the Anti-SARS-CoV-2 Omicron ELISA (IgG). Both test systems enable the detection of IgG antibodies formed against
Reliable and fast diagnostics of cervical cancer While HPV tests detect infections with HPV and thus allow drawing conclusions on the risk of developing cervical cancer, the GynTect® test can be used in a second step to clarify whether affected cells are actually already developing into cancer cells based on the detection of epigenetic markers.
At the end of March 2022, the German Health Ministers’ Conference dealt with the topic of “vaccinations and medical care for Ukrainian refugees,” due to seemingly large vaccination gaps among the Ukrainian population and the circumstances under which refugees often initially live – many people in a small space with comparatively poor hygienic conditions. These
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 13. article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany I often receive questions from dermatologists describing events in their mycological mail-in laboratory. In my opinion, the establishment of local laboratory collectives is an excellent development.
